US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 22, 2013 (14 years ago)

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Crystallization: Active pharmaceutical ingredient is precipitating in product solution.

What was recalled

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.

Recalling firm
Fresenius Kabi USA LLC (FK USA)
NDC code
63323-193-02
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-915-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all